November 15, 2004
Stevens-Johnson syndrome induced by paclitaxel in a patient with squamous cell carcinoma of the lung: a case report.Topics: Clinical Pharmacology
nticancer Res. 2004 Mar-Apr;24(2C):1135-7.
Hiraki A, Aoe K, Murakami T, Maeda T, Eda R, Takeyama H.
A 53-year-old man was treated with advanced squamous cell carcinoma of the lung who had developed Stevens-Johnson syndrome, a life-threatening cutaneous reaction, after systemic chemotherapy consisting of carboplatin and paclitaxel. A critical assessment disclosed circumstantial evidence pointing to paclitaxel as the likely cause of this complication. As far as we are aware, this account is the first description of a paclitaxel-induced Stevens-Johnson syndrome. This case serves as an alert for the need to observe patients closely for potentially dangerous cutaneous reactions to paclitaxel therapy.
Posted by Hyscience at November 15, 2004 10:30 AM
Articles Related to Clinical Pharmacology:
- Stevens-Johnson syndrome induced by paclitaxel in a patient with squamous cell carcinoma of the lung: a case report. - Nov 15, 2004